NCT07546435

Brief Summary

Several international studies indicate that men with reduced semen quality often feel overlooked in the context of fertility treatment. Men who undergo fertility treatment due to their own infertility, exhibit increased concern and experience more negative emotions such as loss, stigmatization, and low self-esteem - more so than men undergoing fertility treatment for other reasons. Since 2008, there has been limited research on the experiences of male patients with infertility in Denmark. Furthermore, there is generally very little knowledge regarding the testosterone levels (hypogonadism) of male infertile patients and its association with quality of life. Thus, there is a lack of updated insight into how infertile men experience their situation today. Additionally, the present study finds it relevant to examine whether men's needs and experiences in interactions with health professionals have changed over the past 15 years.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
33mo left

Started Feb 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Feb 2026Jan 2029

Study Start

First participant enrolled

February 13, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 26, 2026

Completed
27 days until next milestone

First Posted

Study publicly available on registry

April 22, 2026

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2029

Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

2.9 years

First QC Date

March 26, 2026

Last Update Submit

April 16, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Questionnaire of male experience of involvement in fertility treatment

    From the start of fertility treatment to registration of pregnancy test

  • Change in patient-experience when compared to the 2008 study conducted at The University Clinic for Fertility, Regional Hospital Skive by using the same questionaire

    From the start of fertility treatment to registration of pregnancy test

  • Correlation between male serum testosterone level and quality of life evaluated from questionnaire

    From the start of fertility treatment to registration of pregnancy test

Secondary Outcomes (3)

  • Questionnarie about the prevalence of psychological and social burden i fertility treatment

    From the start of fertility treatment to registration of pregnancy test

  • A comparison between men with reduced semen quality and men without reduced semen quality focusing on the prevalence of psychological and social burden, desire to communicate with health professionals, and serum testosterone level and life quality

    From the start of fertility treatment to registration of pregnancy test

  • Classification of the examined population into APHRODITE groups

    From the start of fertility treatment to end of study

Study Arms (2)

Infertile males

Males with reduced semen quality according to WHO 2021 6th edition

Fertile males

Males normal semen quality according to WHO 2021 6th edition

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Male patients of infertile couples initiating fertility treatment. Both male with normal sperm parametres and male with reduced sperm parametres

You may qualify if:

  • ICSI treatment caused by reduced semen quality, language (danish)

You may not qualify if:

  • PESA/TESA, Cancer, Sterilized males

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Regionshospitalet

Skive, Midt Jylland, 7800, Denmark

RECRUITING

MeSH Terms

Conditions

Hypogonadism

Condition Hierarchy (Ancestors)

Gonadal DisordersEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
4 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 26, 2026

First Posted

April 22, 2026

Study Start

February 13, 2026

Primary Completion (Estimated)

January 15, 2029

Study Completion (Estimated)

January 15, 2029

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations